机译:同种异体血液或骨髓移植后的晚期死亡率用于原始的新陈代谢:血液或骨髓移植幸存者研究-2(BMTSS-2)的报告
Univ Alabama Birmingham Dept Pediat Div Pediat Hematol &
Oncol Birmingham AL USA;
Univ Alabama Birmingham Inst Canc Outcomes &
Survivorship Birmingham AL USA;
Lund Univ Skane Univ Hosp Dept Clin Sci Pediat Oncol &
Hematol Lund Sweden;
Univ Alabama Birmingham Inst Canc Outcomes &
Survivorship Birmingham AL USA;
Univ Alabama Birmingham Inst Canc Outcomes &
Survivorship Birmingham AL USA;
Univ Alabama Birmingham Inst Canc Outcomes &
Survivorship Birmingham AL USA;
Univ Alabama Birmingham Inst Canc Outcomes &
Survivorship Birmingham AL USA;
Univ Alabama Birmingham Inst Canc Outcomes &
Survivorship Birmingham AL USA;
Univ Alabama Birmingham Inst Canc Outcomes &
Survivorship Birmingham AL USA;
Univ Minnesota Div Pediat Cardiol Minneapolis MN USA;
Univ Minnesota Div Hematol Oncol &
Transplantat Minneapolis MN USA;
Univ Minnesota Div Hematol Oncol &
Transplantat Minneapolis MN USA;
City Hope Natl Med Ctr Pediat Hematol &
Oncol Duarte CA USA;
Univ Minnesota Div Hematol Oncol &
Transplantat Minneapolis MN USA;
Univ Minnesota Div Hematol Oncol &
Transplantat Minneapolis MN USA;
Univ Alabama Birmingham Dept Pediat Div Pediat Hematol &
Oncol Birmingham AL USA;
Blood or marrow transplantation; Inborn errors of metabolism; Late mortality;
机译:同种异体血液或骨髓移植后的晚期死亡率用于原始的新陈代谢:血液或骨髓移植幸存者研究-2(BMTSS-2)的报告
机译:移植原始新陈代谢误差(IEM)的患者的晚期死亡率 - 来自血液或骨髓移植幸存者研究-2(BMTSS-2)的报告
机译:移植原始新陈代谢误差(IEM)的患者的晚期死亡率 - 来自血液或骨髓移植幸存者研究-2(BMTSS-2)的报告
机译:血液发作干细胞移植(HSCT)用于阵发性夜间血红蛋白(PNH)和获得的严重Aplastic Anemta(SAA):来自欧洲血液和骨髓移植组的SAA工作组(EBMT)的报告
机译:通过匹配的无关供体同种异体造血或骨髓移植(URD-BMT)治疗的高危患者中,通过细胞遗传学,年龄和性别进行的与急性淋巴细胞白血病(ALL)异质遗传关联的证据
机译:儿童自体血液或骨髓移植后的晚期死亡率:血液或骨髓移植幸存者研究2报告
机译:同种异体血液或骨髓移植后的晚期死亡率用于原始的新陈代谢:血液或骨髓移植幸存者研究-2(BMTSS-2)的报告